Information Journal Paper
APA:
Copy. (2017). Atezolizumab: A PD-L1-blocking antibody for bladder cancer. CLINICAL CANCER RESEARCH, 23(8), 1886-1890. SID. https://sid.ir/paper/765409/en
Vancouver:
Copy. Atezolizumab: A PD-L1-blocking antibody for bladder cancer. CLINICAL CANCER RESEARCH[Internet]. 2017;23(8):1886-1890. Available from: https://sid.ir/paper/765409/en
IEEE:
Copy, “Atezolizumab: A PD-L1-blocking antibody for bladder cancer,” CLINICAL CANCER RESEARCH, vol. 23, no. 8, pp. 1886–1890, 2017, [Online]. Available: https://sid.ir/paper/765409/en